Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

BOSTON — Key DNA and chromosomal and immune cell changes in early-stage lung adenocarcinoma show significant associations with outcomes, representing potentially important early predictors to ...

An AI-based EGFR biomarker tool could preclude the need for a rapid PCR test in nearly half of advanced lung adenocarcinoma cases, a study has suggested.

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to lung adenocarcinoma cells, dramatically suppressing tumor growth in ...

In November, when I was diagnosed with EGFR-mutated lung cancer, I had adenocarcinoma in my left lung.With follow-up tests in the hospital, I learned it had spread to include lesions and lymph ...

Lung adenocarcinoma tumor cells (green) and macrophages (red) accumulate in the lungs of control mice (left), but expansion of the tumor cells is hindered in macrophage PPARγ knockout mice (right ...

Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors ...

Background and objectives. Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in ...

Tubulis announced today that the first patient has been treated in its first Phase I/IIa trial (NAPISTAR 1-01, NCT06303505). The study is evaluating T ...